These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3899922

  • 21. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC, Weitzen ML, Kahle R, Granger GA, Bonavida B.
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
    Degliantoni G, Murphy M, Kobayashi M, Francis MK, Perussia B, Trinchieri G.
    J Exp Med; 1985 Nov 01; 162(5):1512-30. PubMed ID: 3932579
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity.
    Wright SC, Bonavida B.
    Proc Natl Acad Sci U S A; 1983 Mar 01; 80(6):1688-92. PubMed ID: 6572932
    [Abstract] [Full Text] [Related]

  • 28. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
    Ortaldo JR, Ransom JR, Sayers TJ, Herberman RB.
    J Immunol; 1986 Nov 01; 137(9):2857-63. PubMed ID: 3093586
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity.
    Bonavida B, Wright SC.
    Adv Exp Med Biol; 1982 Nov 01; 146():379-88. PubMed ID: 7102465
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Killing of tumor cells with pleiotropic drug resistance by OK432-activated effector cells.
    Allavena P, Peccatori F, Maggioni D, Pirovano P, Mantovani A.
    Immunopharmacol Immunotoxicol; 1989 Nov 01; 11(2-3):257-68. PubMed ID: 2621319
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [In vivo augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432: characterization of effector cells and induction of interferon in sera (author's transl)].
    Wakasugi H, Miyata M, Morioka Y, Oshimi K, Kasahara T, Takahashi K, Saito M, Ebina T.
    Nihon Gan Chiryo Gakkai Shi; 1981 Jun 20; 16(3):433-46. PubMed ID: 7320603
    [No Abstract] [Full Text] [Related]

  • 38. Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.
    Yamaue H, Katsumi M, Tabuse K, Tabuse Y, Kuribayashi K, Nishihara T, Saito K.
    Cancer Immunol Immunother; 1987 Jun 20; 25(3):169-74. PubMed ID: 3315203
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
    Pedersen BK, Oxholm P.
    Clin Exp Immunol; 1988 May 20; 72(2):299-302. PubMed ID: 3409548
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.